The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Nexalin Technology Inc (NASDAQ: NXL) closed the day trading at $0.69 down -3.88% from the previous closing price of $0.72. In other words, the price has decreased by -$3.88 from its previous closing price. On the day, 0.26 million shares were traded. NXL stock price reached its highest trading level at $0.715 during the session, while it also had its lowest trading level at $0.645.
Ratios:
For a better understanding of NXL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.03 and its Current Ratio is at 13.47. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 10 ’25 when Elson Marilyn bought 23,150 shares for $0.02 per share.
Shelton Carolyn Hamby bought 6,000 shares of NXL for $13,200 on Mar 12 ’25. The Sr. VP – Quality, Regulatory now owns 30,000 shares after completing the transaction at $2.20 per share. On Feb 04 ’25, another insider, Owens David, who serves as the Chief Medical Officer of the company, bought 1,000 shares for $3.10 each. As a result, the insider paid 3,100 and bolstered with 155,793 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NXL now has a Market Capitalization of 12909007 and an Enterprise Value of 8556330. For the stock, the TTM Price-to-Sale (P/S) ratio is 80.68 while its Price-to-Book (P/B) ratio in mrq is 2.64. Its current Enterprise Value per Revenue stands at 54.523 whereas that against EBITDA is -0.969.
Stock Price History:
The Beta on a monthly basis for NXL is 3.88, which has changed by -0.75 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, NXL has reached a high of $3.87, while it has fallen to a 52-week low of $0.70. The 50-Day Moving Average of the stock is -40.03%, while the 200-Day Moving Average is calculated to be -44.15%.
Shares Statistics:
Over the past 3-months, NXL traded about 3.49M shares per day on average, while over the past 10 days, NXL traded about 177180 shares per day. A total of 18.19M shares are outstanding, with a floating share count of 14.40M. Insiders hold about 22.82% of the company’s shares, while institutions hold 3.73% stake in the company. Shares short for NXL as of 1764288000 were 104655 with a Short Ratio of 0.01, compared to 1761868800 on 577449. Therefore, it implies a Short% of Shares Outstanding of 104655 and a Short% of Float of 0.64999997.
Earnings Estimates
A detailed examination of Nexalin Technology Inc (NXL) is currently in progress, with 1.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.12 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.49 and -$0.49 for the fiscal current year, implying an average EPS of -$0.49. EPS for the following year is -$0.39, with 1.0 analysts recommending between -$0.39 and -$0.39.
Revenue Estimates
1 analysts predict $80k in revenue for. The current quarter. It ranges from a high estimate of $80k to a low estimate of $80k. As of. The current estimate, Nexalin Technology Inc’s year-ago sales were $27.18kFor the next quarter, 1 analysts are estimating revenue of $100k. There is a high estimate of $100k for the next quarter, whereas the lowest estimate is $100k.
A total of 1 analysts have provided revenue estimates for NXL’s current fiscal year. The highest revenue estimate was $231k, while the lowest revenue estimate was $231k, resulting in an average revenue estimate of $231k. In the same quarter a year ago, actual revenue was $168.72kBased on 1 analysts’ estimates, the company’s revenue will be $660k in the next fiscal year. The high estimate is $660k and the low estimate is $660k.
